KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Payables (2016 - 2025)

Historic Payables for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $87.2 million.

  • Globus Medical's Payables rose 5160.16% to $87.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.2 million, marking a year-over-year increase of 5160.16%. This contributed to the annual value of $75.1 million for FY2024, which is 3255.1% up from last year.
  • According to the latest figures from Q3 2025, Globus Medical's Payables is $87.2 million, which was up 5160.16% from $87.1 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Payables registered a high of $87.2 million during Q3 2025, and its lowest value of $20.7 million during Q3 2021.
  • For the 5-year period, Globus Medical's Payables averaged around $48.9 million, with its median value being $39.8 million (2023).
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 17191.52% in 2023, then plummeted by 3381.53% in 2024.
  • Quarter analysis of 5 years shows Globus Medical's Payables stood at $22.0 million in 2021, then soared by 64.43% to $36.1 million in 2022, then soared by 56.98% to $56.7 million in 2023, then surged by 32.55% to $75.1 million in 2024, then increased by 16.12% to $87.2 million in 2025.
  • Its Payables stands at $87.2 million for Q3 2025, versus $87.1 million for Q2 2025 and $73.1 million for Q1 2025.